Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01236365Phase 3Completed
Phase 3, randomised, double-blind trial in hypercholesterolemia comparing Atorvastatin with Placebo (2 arms). Primary endpoints: Low-Density Lipoprotein Cholesterol at 6 months and High-Sensitivity C-Reactive Protein at 6 months. Started Oct 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01236365.